Acadia Pharmaceuticals Stock Market Value
| ACAD Stock | USD 19.00 0.01 0.05% |
| Symbol | ACADIA |
ACADIA Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACADIA Pharmaceuticals. If investors know ACADIA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACADIA Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 28.347 | Earnings Share 0.78 | Revenue Per Share | Quarterly Revenue Growth 0.183 | Return On Assets |
The market value of ACADIA Pharmaceuticals is measured differently than its book value, which is the value of ACADIA that is recorded on the company's balance sheet. Investors also form their own opinion of ACADIA Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ACADIA Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACADIA Pharmaceuticals' market value can be influenced by many factors that don't directly affect ACADIA Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACADIA Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ACADIA Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACADIA Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ACADIA Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ACADIA Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ACADIA Pharmaceuticals.
| 01/27/2025 |
| 02/26/2025 |
If you would invest 0.00 in ACADIA Pharmaceuticals on January 27, 2025 and sell it all today you would earn a total of 0.00 from holding ACADIA Pharmaceuticals or generate 0.0% return on investment in ACADIA Pharmaceuticals over 30 days. ACADIA Pharmaceuticals is related to or competes with Madrigal Pharmaceuticals, Viking Therapeutics, Sarepta Therapeutics, Hepion Pharmaceuticals, PTC Therapeutics, Reviva Pharmaceuticals, and Athira Pharma. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small mole... More
ACADIA Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ACADIA Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ACADIA Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.49 | |||
| Information Ratio | 0.0658 | |||
| Maximum Drawdown | 15.53 | |||
| Value At Risk | (4.22) | |||
| Potential Upside | 5.34 |
ACADIA Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ACADIA Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ACADIA Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use ACADIA Pharmaceuticals historical prices to predict the future ACADIA Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0596 | |||
| Jensen Alpha | 0.196 | |||
| Total Risk Alpha | 0.179 | |||
| Sortino Ratio | 0.0779 | |||
| Treynor Ratio | 0.3395 |
ACADIA Pharmaceuticals Backtested Returns
ACADIA Pharmaceuticals appears to be not too volatile, given 3 months investment horizon. ACADIA Pharmaceuticals retains Efficiency (Sharpe Ratio) of 0.11, which signifies that the company had a 0.11 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for ACADIA Pharmaceuticals, which you can use to evaluate the volatility of the entity. Please makes use of ACADIA Pharmaceuticals' coefficient of variation of 1411.9, and Market Risk Adjusted Performance of 0.3495 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, ACADIA Pharmaceuticals holds a performance score of 8. The firm owns a Beta (Systematic Risk) of 0.59, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ACADIA Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding ACADIA Pharmaceuticals is expected to be smaller as well. Please check ACADIA Pharmaceuticals' mean deviation, standard deviation, treynor ratio, as well as the relationship between the downside deviation and total risk alpha , to make a quick decision on whether ACADIA Pharmaceuticals' current price history will revert.
Auto-correlation | 0.39 |
Below average predictability
ACADIA Pharmaceuticals has below average predictability. Overlapping area represents the amount of predictability between ACADIA Pharmaceuticals time series from 27th of January 2025 to 11th of February 2025 and 11th of February 2025 to 26th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ACADIA Pharmaceuticals price movement. The serial correlation of 0.39 indicates that just about 39.0% of current ACADIA Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.39 | |
| Spearman Rank Test | 0.1 | |
| Residual Average | 0.0 | |
| Price Variance | 0.27 |
ACADIA Pharmaceuticals lagged returns against current returns
Autocorrelation, which is ACADIA Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ACADIA Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of ACADIA Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that ACADIA Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ACADIA Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ACADIA Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ACADIA Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ACADIA Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
ACADIA Pharmaceuticals Lagged Returns
When evaluating ACADIA Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ACADIA Pharmaceuticals stock have on its future price. ACADIA Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ACADIA Pharmaceuticals autocorrelation shows the relationship between ACADIA Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in ACADIA Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ACADIA Pharmaceuticals is a strong investment it is important to analyze ACADIA Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ACADIA Pharmaceuticals' future performance. For an informed investment choice regarding ACADIA Stock, refer to the following important reports:Check out ACADIA Pharmaceuticals Correlation, ACADIA Pharmaceuticals Volatility and ACADIA Pharmaceuticals Alpha and Beta module to complement your research on ACADIA Pharmaceuticals. For information on how to trade ACADIA Stock refer to our How to Trade ACADIA Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
ACADIA Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.